key: cord-0686799-50k6pfxr authors: Hamza, Muhammad; Alsma, Jelmer; Kellett, John; Brabrand, Mikkel; Christensen, Erika F.; Cooksley, Tim; Haak, Harm R.; Nanayakkara, Prabath W.B.; Merten, Hanneke; Schouten, Bo; Weichert, Immo; Subbe, Christian P. title: Can vital signs recorded in patients’ homes aid decision making in emergency care? A Scoping Review date: 2021-04-10 journal: Resusc Plus DOI: 10.1016/j.resplu.2021.100116 sha: c9c6e05330526b17f0624323324281519d5b17ee doc_id: 686799 cord_uid: 50k6pfxr AIM: Use of tele-health programs and wearable sensors that allow patients to monitor their own vital signs have been expanded in response to COVID-19. We aimed to explore the utility of patient-held data during presentation as medical emergencies. METHODS: We undertook a systematic scoping review of two groups of studies: studies using non-invasive vital sign monitoring in patients with chronic diseases aimed at preventing unscheduled reviews in primary care, hospitalization or emergency department visits and studies using vital sign measurements from wearable sensors for decision making by clinicians on presentation of these patients as emergencies. Only studies that described a comparator or control group were included. Studies limited to inpatient use of devices were excluded. RESULTS: The initial search resulted in 896 references for screening, nine more studies were identified through searches of references. 26 studies fulfilled inclusion and exclusion criteria and were further analyzed. The majority of studies were from telehealth programs of patients with congestive heart failure or Chronic Obstructive Pulmonary Disease. There was limited evidence that patient held data is currently used to risk-stratify the admission or discharge process for medical emergencies. Studies that showed impact on mortality or hospital admission rates measured vital signs at least daily. We identified no interventional study using commercially available sensors in watches or smart phones. CONCLUSIONS: Further research is needed to determine utility of patient held monitoring devices to guide management of acute medical emergencies at the patients’ home, on presentation to hospital and after discharge back to the community. The COVID-19 pandemic has resulted in an increase in the number of virtual wards 1 that are monitoring patients in their own home to detect deterioration and the need for hospital admission. In traditional practice the decision about the need of an individual to require admission to a hospital relies on the assessment of patients' symptoms, signs, past-medical history, diagnosis and social support at home 2À4 and a judgment of the severity of illness based on an estimated risk of deterioration in the subsequent hours and days. 5 Abnormalities of vital signs are quantified by comparison with 'normal' measurements of healthy individuals during periods of physiological stability. Within these individuals the 'normal' measurements vary and are influenced by genetic determinants, age, sex, body composition, medications and physical condition. There is an association between the magnitude of change from a physiological normal range, the number of vital signs affected by the disease state and the frequency of adverse events. 6, 7 Abnormality can be scored with generic tools that can be applied to the majority of patients such as the National Early Warning Score (NEWS). 8 However these scores can under-or overestimate risk in individual patients. 9 In patients with chronic conditions such as chronic heart failure (CHF) or chronic obstructive pulmonary disease (COPD) 10 vital signs are often not comparable to those of healthy individuals even during times of stability. In order to assess the severity of illness of a patient with chronically abnormal vital signs clinicians might compare measurements on presentation to hospital with values derived from previous clinical encounters such as outpatient clinic visits, primary care attendances or records from previous hospital admissions but do usually not know what the patient's measurements are in their own living and working life. Patients with heart failure are likely to have chronically low pulse pressure 11 and patients with COPD often have a higher heart rate, respiratory rate and lower oxygen saturations than patients without this condition. 12 Beyond this, physiological reserve might also affect the degree of physiological abnormality in response to a disease. 13 Knowing the values of an individual patient's vital signs during a period of relative wellness might therefore help clinicians to understand trends 14 and the degree of deviation from normal and hence the severity of illness of a patient. Individual vital signs (e.g., heart rate, heart rhythm, oxygen saturation) can easily be measured by smartwatches and mobile telephones. Smart monitoring devices allow data to be captured and interpreted by apps; connection to the internet allows data to be shared in real time with others. Currently, 49 À83% of the population of European countries and 79% of the United States use smartphones, and this number is rising. 15 According to the Institute of Medicine, the quality of interventions can be defined in six dimensions 16 : safety, effectiveness, patientcenteredness, timeliness, efficiency, and equity. Applied to acute care we would therefore hypothesizes that wearable monitors would need to demonstrate 1. improvements in the way that risk is quantified and managed, 2. effectiveness in identifying a significant change in the physiological status of a person earlier than current methods and in real time, 3 . the ability of patients to review and manage their own risk according to their preferences, 4. the capability to link into protocols that use the data to initiate more timely treatment before catastrophic deterioration in the community, and finally 5. the ability of more citizens to have access to high quality monitoring of their health. In this review we aimed to map the literature on how measurements of vital signs taken by patients at home might inform decisionmaking on presentation to hospital or other emergency services and identify gaps for future research. We performed a scoping review using Arksey and O'Malley's methodology and Levac's conceptual extension. 17, 18 We followed the five-step process proposed by O'Malley's: 1. Identification of the research question: The research question was formulated through an iterative process after a cursory screening of the literature. Consensus on the search terms, inclusion of studies and themes for synthesis were achieved during conference calls between the authors. We identified two related topics for examination: a. Long-term monitoring: How has non-invasive vital sign monitoring been used in patients with chronic diseases to prevent unscheduled reviews in primary care, hospitalization or emergency department (ED) visits? b. Opportunistic utilization: How are vital sign measurements from wearable sensors utilized by clinicians on presentation to emergency services such as out-of-hours primary care services, emergency departments or acute medical units? Given that current wearable sensors are able to measure vital signs and mobility both areas were included in the search. 2. Identification of relevant studies was through relevant MESH terms: "Telemedicine" and "Wearable Electronic Devices" and "Smartphone" were combined with "Vital Signs" and "Mobility Limitation". The searches were conducted on MEDLINE, EMBASE and the Cochrane Library. The search was limited to studies published on or before March 31st 2020. The search terms that were used in the literature review are present in the appendix. The search was undertaken in March of 2020 with additional searches undertaken in October 2020 and January 2021. Inclusion criteria: Included were studies in adult patients that used non-invasive devices to measure at least one vital sign and tracked unscheduled visits to primary care, emergency department or admission to hospital in such patients. Only interventional or observational studies with a comparator or control group were included. Exclusion criteria: pilot or feasibility studies, conference presentations; vital sign recordings limited to inpatient settings, and studies without information about the monitoring device. Additional searches were undertaken against a representative sample of leading brand names: a search for studies involving Apple Watch resulted in two case studies, 19, 20 The original search conducted in March 2020 yielded 896 potentially relevant citations. After screening 94 citations met the inclusion criteria based on title and abstract and the corresponding full text articles were procured for review. After sight of the full text 26 articles were included in the study ( Fig. 1 : Flow diagram). Adding 'mobility limitations' to the search resulted in no additional studies. Two studies used the same dataset with different outcome measures. 21, 22 Of the 26 studies fulfilling our inclusion criteria three originated from the US, 21À23 five from the UK, 24À28 three from Spain, 29À31 three from Italy 32À34 and one from Germany, 35 Taiwan, 36 Japan, 37 Finland, 38 Belgium, 39 Holland, 40 Australia, 41 New Zealand 42 and Denmark. 43 Three studies were multi-center trials from Europe. 44À46 24 studies were randomized controlled trials and 2 studies were before and after comparisons. Characteristics of the interventions are summarized in Table 1 and measurements and clinical outcomes in Table 2 . Specified devices included the Sweetage TM wrist wearable device, 32 Intel TM health telemonitoring device, 21, 22 Wrist Clinic wearable device TM , 46 Motiva system TM , 27, 47 Honeywell Home Med TM28, 25 and a Tanita device designed to measure body-composition. 37 Twenty three studies used standard medical devices and manual data entry or modems to monitor the vital signs 21À28,30,31,34À45,47 while two studies used a wearable electronic device for monitoring. 32, 46 Details on characteristics of monitoring devices was missing in one study. 48 Information was transferred through a secure broadband internet connection was in eleven studies 21,22,24,26,27,31,36À38,43,47 whilst cellular communication devices were utilized in five studies 32, 35, 39, 40, 46 and communication through a telephone line was used in nine studies. 23, 25, 28, 30, 34, 41, 42, 44, 45 Devices in four studies had built in transmission capability via the internet: Two of these were wearable electronic devices (Sweetage TM , 32 Wristclinic TM46 ); the other two utilized an Intel Health TM Telemonitoring device. 21, 22 Parameters measured Twenty three studies evaluated tele-monitoring devices while two studies ,32,46 reported on the use of wearable electronic device: studies involving telemonitoring utilized between one and five vital signs ( Table 2) : Heart rate (n=11) and weight (n=14) were the most commonly monitored vital sign in studies on heart failure (n=16) whereas oxygen saturation (n=13) was most commonly monitored in studies on COPD (n=13). Blood pressure was the most measured variable among all the telemonitoring studies (n=20) followed by weight (n=18), heart rate (n=17), oxygen saturation (n=17), electrocardiogram (n=4), temperature (n=3) and spirometry (n=3) ( Table 2) . Two studies used wearable wrist devices to measure heart rate, temperature, blood pressure, pulse oximetry. 32, 46 Forced Oscillation Technique, 46 a non-invasive method that evaluates the resistance and reactance of the respiratory system, was used in COPD patients. Telemetric measurements were taken at variable intervals: once, 38,43,45 twice 23 or thrice weekly, 33 once daily 21,22,24À28,30,31,35 À37,39À42,47 or twice daily. 44 One study had variable monitoring regime. 43 In the two studies using wearable electronic device one study monitored five times a day 32 while the other monitored once daily. 46 Monitoring with patient questionnaires Twelve out of 21 selected telemedicine studies utilized a subjective assessment of patient's symptoms in the form of a questionnaire along with the vital signs to anticipate worsening. 24À26 These questionnaires were completed digitally or were communicated verbally by telephone. Out of these twelve, four studies demonstrated a reduction in number of hospitalisations or length of stay. 26,29À31 Response to abnormal Vital signs Responses to abnormal vital signs could be in real time/instantaneous or scheduled/intermittent. Full details of the telemonitoring protocol were available for all the studies (Table 1) : Protocols in eight studies involved the use of automatic computer algorithms for patient risk assessment. 30,31,36,39,40,44À46 These algorithms were either based on a pre-defined alarm limits for vital signs or a dynamic range based on historical vital signs of the individual patient. Only patients with measurements outside the alarm limits were reviewed by clinical staff. Six of these studies 30, 31, 36, 39, 44, 46 demonstrated significant reduction in hospitalization and mortality. In 15 studies, all the data obtained from the patients was monitored regularly by clinical staff, of these, three 26, 34, 48 showed improved clinical outcomes. Three studies combined both automated algorithms and direct monitoring, 24, 27, 35 of these one 35 showed statistically significant reduction in hospitalization. Abnormal vital signs resulted in a number of interventions: lifestyle and/or medication advice, medication review and adjustments, video conferences, primary care referrals, home visits, secondary care referrals and admissions to hospital (Table 1 ). Ten studies evaluated the impact of telemonitoring in CHF 25,29,35,37 À40,44,45,48 but wearable technology was not evaluated. Improvement in chosen clinical outcomes for chronic heart failure patients was associated with the frequency of vital sign monitoring: Five of eight studies that measured vital signs at least daily 29, 35, 39, 44 vs none that used weekly 38, 45 monitoring. Weight, 25,29,35,37À40,44,45 heart rate 25,29,35,37À39,44,45,48 and blood pressure 25,29,35,37À40,44,45,48 were monitored in almost all the studies whereas oxygen saturation was measured in only three 25, 35, 48 of which two studies 35, 48 could demonstrate reduced hospitalisations in the intervention group. ECG was monitored in 4 studies 35, 40, 44, 45 out of which two studies showed significant reduction in number of hospital admissions or duration of admissions 35, 44 (Table 2) . Nine studies 24 Sweetage TM and Wrist clinic TM . In most of these studies patients were monitored daily, and all measured oxygen saturation: one also measured spirometry, 43 one measured peak expiratory flow 30 and one study used Forced Oscillation Technique. 46 Two out of the seven telemonitoring studies 30, 36 showed significant reduction in hospitalisations and emergency room visits while only one 46 study using wearable electronic devices could demonstrate improvement. Two of the three studies which showed significant improvement used some measure of lung function for monitoring 30, 46 (Table 2) . Seven studies 21À23,26,31,34,42 evaluated the impact of telemonitoring on a general population with a variety of diseases such as COPD, heart failure, diabetes, cancer, dementia, chronic wound care, renal failure, chronic respiratory failure and stroke ( Table 2 ). All studies used conventional devices. Three 26,31,34 showed significant reduction in hospitalisations. The largest clinical trial in this group, with 2762 patients who were followed for a year, showed significant reduction in hospital bed days. 26 Patients with heart failure and COPD were present in all the studies ( Table 2) . Outcomes were compared in parallel groups between monitored and unmonitored patients in 24 studies. The remaining two studies were pre-post-intervention studies. 47, 48 Clinical outcomes in studies of telemonitoring included emergency presentations to primary care, rate of hospital admissions, duration of admission, time to hospital admission, healthcare cost and mortality ( Table 2) . Four studies used a composite outcome of hospitalizations and mortality. 35, 37, 40, 45 Clinical outcomes in studies of wearable sensors included number of hospitalizations 32 and disease exacerbations, 32 time to admissions, 46 re-hospitalizations 46 and length of stay. 46 Interventions in 12 studies 24À28, 30, 32, 34, 35, 37, 42, 46 were progressively escalated (advice, medication adjustments, home visits, referrals and admissions) based on the severity of vital sign derangements and their symptoms; five of these studies 26, 30, 34, 35, 46 demonstrated a statistically significant reduction in hospitalizations and/or mortality. 13 21À23,43À45,47,31,36,38À41 studies utilized a single intervention regardless of severity (medical advice, medication review or referral); five of these studies 31, 36, 39, 44, 47 demonstrated statistically significant reduction in hospitalization. Significant reductions in either number of hospitalizations and/or mortality in the monitored group occurred in only 11 out of 26 studies: five in heart failure patients, 29, 35, 39, 44, 48 three in COPD 30, 36, 46 and three in patients with multiple conditions. 26, 31, 34 This review identified significant gaps in the existing literature. No studies described the use of patient held data on admission to hospital to support decision making about clinical care, admission, or discharge. Vulnerable and high-risk patient groups were excluded from some of the studies, yet these might have been the very patients with most to gain from trend analysis of vital signs available on arrival to hospital. Moreover, despite the availability of an accelerometer on every smart phone, we found no study considered prior mobility for triage decisions. This focused scoping review only examined manuscripts from peerreviewed journals and included only fully licenced (i.e., FDA or CE marked) devices and no prototypes. We did not include trials that are currently in progress and have not been reported yet. We are unsure how many studies might have been reported outside of peer-reviewed journals in lifestyle or consumer magazines. In most trials, vital signs were recorded infrequently using conventional devices. Only two studies used wearable devices that performed measurements as frequently as every hour and transmitted this data directly to a remote database. Therefore, impact of using continuous monitoring of vital signs with wearable devices could not be appraised. The use of wearables for clinical research might be currently limited by battery life and might increase as battery technology advances. Telemonitoring has been focused predominantly on patients with two disease groups: COPD and heart failure. Almost all studies that reported statistically significant results used measurements that were performed at least once per day. We found no evidence of use in other patient groups with common chronic physiological abnormalities such as asthma, atrial fibrillation, glomerulonephritis, or liver cirrhosis. Several studies did not include patients with cognitive impairments and those with end-stage disease. Consumer grade vital sign monitoring has been available for over 15 years and vital signs can be measured by patients even without medical grade sensors. 49 Anecdotal reports about the utility of wearables to identify significant illness have been published, 20,50 but the Apple Watch series 3 linked to an external KardiaBand 51,52 and Apple Watch series 4 are the first consumer device that were licensed as a medical device by the U.S. Food and Drug Administration (FDA) for its ability to record an electro-cardiogram (ECG) to detect rhythm abnormalities. 53, 54 Longitudinal monitoring of trends in heart rate have predictive power but the clinical application is far from clear 55, 56 and health-economic evaluations of the older generation of tele-medicine devices might not be cost-efficient. 57, 58 Understanding of trends in vital signs is important for the whole patient journey before, during and after assessment in an emergency department 59 or acute medical unit. 60 Algorithms and Artificial Intelligence may bring a new age of safety to healthcare. However, machine learning requires large amounts of data that is current, correct and complete, and the number of patients currently enrolled in studies so far reported may not be sufficient. Wearables have also been suggested as a tool for pre-hospital triage in major disasters 61 and can be used to predict long term health outcomes: A review found only eight studies predicting either long-term mortality or readmissions to hospital. 62 Given the large amount of devices sold the small number of published studies still seems curious. It remains to be seen if the participation of patients in their own monitoring is empowering and improves care or creates needless anxiety as patients notice fluctuations on their vital signs that are within the normal range. There are also real concerns around digital inclusion of frail and elderly patients and about equitable access to services for those with limited digital literacy. Although the need to monitor patients remotely has been thrown into sharp focus by the COVID-19 pandemic, 63,64 the impact of notifications generated by automated systems on workload of already over-stretched clinical teams in primary and secondary care requires further assessment. 65 While intermittent and continuous vital sign monitoring has been a backbone of safe care for patients admitted to hospital 66 or in a clinical prehospital setting, 67 there is currently little literature is available on its use in the community. There are significant gaps in the peer reviewed literature with important opportunities for future research and development. Despite the possibilities of frequent and continuous measurement of vital signs, most studies used conventional devices for home monitoring. There is little evidence that vital signs recorded by patients are used for decision making by clinicians at the hospital front door; this was true for both consumer and medical devices. Only studies that performed measurements at least once per day found measurable impact on mortality and health-economic metrics. More studies are needed to determine if home measured vitals can improve early detection, timely management and holistic recovery of patients presenting to health services with medical emergencies. Immo Weichert revised the manuscript critically for important intellectual content The "virtual wards" supporting patients with covid-19 in the community The decision-making process for unplanned admission to hospital unveiled in hospitalised older adults: a qualitative study Assessing the need for hospital admission by the Cape Triage discriminator presentations and the simple clinical score The simple clinical score: a tool for benchmarking of emergency admissions in acute internal medicine Who will be sicker in the morning? Changes in the Simple Clinical Score the day after admission and the subsequent outcomes of acutely ill unselected medical patients Longitudinal analysis of one million vital signs in patients in an academic medical center Are vital sign abnormalities associated with poor outcomes after emergency department discharge NEWSDIG: the national early warning score development and implementation group Prediction models for mortality in adult patients visiting the Emergency Department: a systematic review CREWS: improving specificity whilst maintaining sensitivity of the National Early Warning Score in patients with chronic hypoxaemia Heart Institute of Japan À Department of Cardiology (HIJC) Investigators. Clinical characteristics and outcome of hospitalized patients with congestive heart failure: results of the HIJC-HF registry Effect of an automated notification system for deteriorating ward patients on clinical outcomes Predicting speed at traffic lights-the problem with static assessments of frailty The value of vital sign trends in predicting and monitoring clinical deterioration: a systematic review Light Version | Newzoo Crossing the quality chasm: a new health system for the 21st century Scoping studies: towards a methodological framework Scoping studies: advancing the methodology Smart watch recording of ventricular tachycardia: case study My watch kept on alarming all night about my heart rate": diagnosis of asymptomatic atrial fibrillation with fast ventricular response in a patient with a recent TIA as the result of a smartwatch alarm Cost comparison between home telemonitoring and usual care of older adults: a randomized trial (Tele-ERA) A randomized controlled trial of telemonitoring in older adults with multiple health issues to prevent hospitalizations and emergency department visits Home telehealth improves clinical outcomes at lower cost for home healthcare Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial) A randomised clinical trial of the effectiveness of home-based health care with telemonitoring in patients with COPD Telemonitorización no invasiva en pacientes ambulatorios con insuficiencia cardiaca: Efecto en el número de hospitalizaciones, días de ingreso y calidad de vida. Estudio CARME (CAtalan Remote Management Evaluation) A home telehealth program for patients with severe COPD: the PROMETE study Impact of telemonitoring home care patients with heart failure or chronic lung disease from primary care on healthcare resource use (the TELBIL study randomised controlled trial) Efficacy of multiparametric telemonitoring on respiratory outcomes in elderly people with COPD: a randomized controlled trial Telemetria per il controllo domiciliare della pressione arteriosa, della frequenza cardiaca e della saturimetria di ossigeno nello scompenso cardiaco: Impatto sulle ospedalizzazioni in un contesto non sperimentale Tele-assistance in chronic respiratory failure patients: a randomised clinical trial Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial Effectiveness of telemonitoring in patients with chronic obstructive pulmonary disease in Taiwan-a randomized controlled trial The first multicenter, randomized, controlled trial of home telemonitoring for Japanese patients with heart failure: home telemonitoring study for patients with heart failure (HOMES-HF) Use of home telemonitoring to support multidisciplinary care of heart failure patients in Finland: randomized controlled trial Effect of a telemonitoring-facilitated collaboration between general practitioner and heart failure clinic on mortality and rehospitalization rates in severe heart failure: the TEMA-HF 1 (TElemonitoring in the MAnagement of Heart Failure) study The value of telemonitoring and ICT-guided disease management in heart failure: results from the IN TOUCH study Telehealth remote monitoring for community-dwelling older adults with chronic obstructive pulmonary disease Telecare for diabetes, CHF or COPD: effect on quality of life, hospital use and costs. A randomised controlled trial and qualitative evaluation Effect of tele health care on exacerbations and hospital admissions in patients with chronic obstructive pulmonary disease: a randomized clinical trial Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study Home telemonitoring in heart failure patients: the HHH study (Home or Hospital in Heart Failure) Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED) Noninvasive remote telemonitoring for ambulatory patients with heart failure: effect on number of hospitalizations, days in hospital, and quality of life. CARME (CAtalan Remote Management Evaluation) Study Telemetry for home control of blood pressure, heart rate and oxygen saturimetry in heart failure: impact on hospitalizations in a non-experimental context Respiratory rates observed over 15seconds compared with rates measured using the RRate app. Practice-based evidence from an observational study of acutely ill adult medical patients during their hospital admission Assessing accuracy of wrist-worn wearable devices in measurement of paroxysmal supraventricular tachycardia heart rate Smartwatch performance for the detection and quantification of atrial fibrillation Accuracy of a smartwatch based single-lead electrocardiogram device in detection of atrial fibrillation How useful is the smartwatch ECG? Large-scale assessment of a smartwatch to identify atrial fibrillation Heart rate monitoring: applications and limitations Wearables for integrative performance and tactic analyses: opportunities, challenges, and future directions Telehealthcare for patients suffering from chronic obstructive pulmonary disease: effects on health-related quality of life: Results from the Danish? s TeleCare North' cluster-randomised trial Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish TeleCare North' cluster-randomised trial The last decade of symptom-oriented research in emergency medicine: triage, work-up, and disposition Changes in vital signs post discharge as a potential target for intervention to avoid readmission A data-driven artificial intelligence model for remote triage in the prehospital environment Using wearable technology to predict health outcomes: a literature review An evaluation of biometric monitoring technologies for vital signs in the era of COVID-19 Novel use of home pulse oximetry monitoring in COVID-19 patients discharged from the emergency department identifies need for hospitalization Continuous monitoring of respiratory rate on general wards what might the implications be for clinical practice The impact of the use of the Early Warning Score (EWS) on patient outcomes: a systematic review The ability of early warning scores (EWS) to detect critical illness in the prehospital setting: a systematic review The authors would like to thank the safer@home consortium for helping to crystalize the idea for the paper and for feedback on draft versions. Christian Subbe, Jelmer Alsma and Harm Haak were responsible for No funding was received for the conduct of this scoping review. Chris Subbe has undertaken Consultancy work and acted as a Principal Investigator for Philips Healthcare. Philips Healthcare produces wearable monitoring devices. The authors report no declarations of interest. Supplementary material related to this article can be found, in the online version, at http://dx.doi.org/10.1016/j.resplu.2021.100116.